He received vincristine on days 4 ([**2-9**]) and 11 ([**2-16**]).
He was reports fever or chills, no sick contacts, no NSAID or Tylenol use, but is on steroids.
ROS: negative for fevers, chills, sore throat, nasal congestion, pain, abdominal pain, n/v/d/constipation, change in urinary habits.
He was treated with heparin for the pulmonary embolus and an IVC filter was placed.
He has received the remainder of his protocol treatment with L-asparaginase omitted due to the pulmonary embolism.
He completed his intensification with high-dose methotrexate and underwent stem cell mobilization in the summer of [**2197**] and then completed his radiation therapy in early [**Month (only) **] and underwent consolidation with intrathecal ARA-C.
He began cycle 2 of consolidation on [**2198-10-8**], where he received 5 days of cytarabine and etoposide last given on [**2198-10-12**].
He was admitted to the neurology service where nerve conduction studies revealed a Guillain-[**Location (un) **] like syndrome as well as a polyneuropathy presumed to be from diabetes mellitus and vincristine.
Complicated by transaminitis requiring dose reduction of 6MP and then a change to thioguannine and chemotherapy break in [**10-30**].
ROS: Denies fevers, weight loss, weight gain, chest pain, shortness of breath, abdominal pain, nausea, vomiting, constipation, BRBPR, change in bowel or bladder habits, hematuria, lower extremity edema .
Past Medical Hx: - ALL (as per above onc history) - Stable peripheral neuropathies in right hand and lower legs/feet - Pulmonary embolism - IVC filter placement - Guillain-[**Location (un) **] syndrome vs. CIDP - Diabetes type 2, on insulin - Concern for NASH   Social History: He is married and works at [**Company 11293**].
Severe iron deposition in Kupffer cells and hepatocytes on special stain.
There are case reports of VOD after chemotherapy with vincristine and other agents.
We received approval from FDA for compassionate use of defibrutide for a non-post transplant patient with VOD.
Began treatment with defibrutide on [**2200-2-28**].
He was started on digoxin, sotalol and diltiazem to maintain sinus rhythm.
Transfusion parameters for defibrutide for INR is <2-2.5 and platelets of >50.
- IVC filter in place.
[**Last Name (un) **] was very involved on last admission and patient was discharged with a detailed insulin regimen based on his changes  in decadron.
Medications on Admission: Medications: (Meds per OMR, [**2200-1-16**]) - Ativan 1mg PO Q6 PRN - Bactrim DS 800-160mg PO QMWF - Dexamethasone 24mg PO daily days [**12-22**] of chemo - Fluconazole 200mg PO daily - Humalog Sliding scale and lantus 25units in the morning.
- Lactulose 15mL TID/QID PRN constipation - Levofloxacin 500mg PO daily - Methotrexate 45mg PO as directed - Nasonex 2 sprays each nostril daily - Prednisone 6.5mg PO daily x 5 days - Protonix 40mg PO daily - Thioguanine 40mg PO daily as directed - Zofran 8mg PO Q8 PRN nausea   Discharge Medications: none  Discharge Disposition: Expired  Discharge Diagnosis: ALL [**Last Name (un) 4584**] [**Location (un) **] Liver Failure Diabetes   Discharge Condition: Expired.
